Abstract:In the vapor-phase hydrogen peroxide (VPHP)-sanitized environment, VPHP uptake by product-contacting components could eventually lead to undesired oxidation of biological drug products. Silicone tubing and primary packaging materials are prominent examples of such product-contacting surfaces that are typically processed/sterilized prior to use. This study investigated the VPHP-uptake tendency of these components and how their respective processing/sterilization methods affect the uptake behaviors. Silicone tubing that was sterilized via autoclave or gamma irradiation exhibited different VPHP uptake patterns—decreased uptake rates post autoclaving vs. increased uptake rates post gamma irradiation. The reduced uptake tendency of autoclaved tubing is maintained for 14 days after sterilization, whereas the uptake tendency of irradiated tubing was mostly reversed to normal levels 1 month after irradiation. Empty glass vials adsorbed hydrogen peroxide via the diffusion of VPHP into the vial with high vial-to-vial variability. Vial pretreatment (i.e., depyrogenation) and surface hydrophilicity/hydrophobicity impacted the uptake tendency. Stoppers and empty syringes also adsorbed hydrogen peroxide but at a relatively low level. The uptake behavior of these components appeared to correlate with water levels at the surface (i.e., hydrophilicity). This study provides process development scientists and engineers an in-depth understanding of the VPHP uptake by critical product-contacting surfaces so that they can mitigate the impact on drug product quality.LAY This study investigated vapor-phase hydrogen peroxide (VPHP) absorption by biopharmaceutical drug products via VPHP uptake by critical product-contacting components during the aseptic manufacturing process with a focus on various pretreatments and processing of these components. Sterilization of silicone tubing by gamma irradiation or autoclaving resulted in different VPHP uptake profiles with different effect durations. Primary packaging components, such as vials, syringes, and stoppers, also showed different levels of VPHP uptake with surface hydrophilicity/hydrophobicity playing a critical role. These outcomes suggested that VPHP uptake is a complex phenomenon and should be carefully considered to minimize its impact on product quality. The approach and outcome of this study can benefit scientists and engineers who develop biological product manufacturing processes by providing an in-depth understanding of drug product process risks.

The Analysis of Electricity Storage Location Sites in the Electric Transmission Grid

Impact of Post Manufacturing Handling of Protein-Based Biologic Drugs on Product Quality and User Centricity

Interactions Between Biological Products and Product Packaging and Potential Approaches to Overcome Them

Successful treatment of large venous malformation with dual wavelength 595 and 1064 nm system

Instability Challenges and Stabilization Strategies of Pharmaceutical Proteins

Stress-mediated polysorbate 20 degradation and its potential impact on therapeutic proteins

Advanced protein formulations

Failure Mode Identification of Insulin Drug Products-Impact of Relevant Stress Conditions on the Quality of the Drug

A comprehensive review on stability of therapeutic proteins treated by freeze-drying: induced stresses and stabilization mechanisms involved in processing

In Vivo Stability of Therapeutic Proteins

Polymer-Based Sustained-Release Dosage Forms for Protein Drugs, Challenges, and Recent Advances

An Audit on Design of Pharmaceutical Packaging

Impact of dimensional variability of primary packaging materials on the break-loose and gliding forces of prefilled syringes

Impact of Different Packaging Configurations on A Topical Cream Product

Vapor-Phase Hydrogen Peroxide Uptake by Silicone Tubing and Primary Packaging Components during Protein Drug Product Aseptic Filling: Impact of Pretreatment and Sterilization Process

Development and Qualification of Visible Particle Load Analysis Methods for Injectable Drug Product Primary Packaging Components

[Cardiac pathology of sudden death].

A Romanian forum for reform.

Pharmaceutical proteins at the interfaces and the role of albumin

High Throughput In-Use and Stress Size Stability Screening of Protein Therapeutics Using Algorithm-Driven Dynamic light scattering.

Improving the Integrity of Pharmaceutical Serialization with Enterprise Technologies